QDEL
Quidel Corporation
NASDAQ: QDEL · HEALTHCARE · MEDICAL DEVICES
$10.80
+0.28% today
Updated 2026-05-08
Market cap
$734.42M
P/E ratio
—
P/S ratio
0.28x
EPS (TTM)
$-17.85
Dividend yield
—
52W range
$10 – $39
Volume
2.3M
WallStSmart proprietary scores
40
out of 100
Grade: D
Sell
Investment rating
2.0
Growth
F4.8
Quality
C2.5
Profitability
F6.3
Valuation
B5/9
Piotroski F-Score
Moderate
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →195 stocks currently score above 75
Price targets
Analyst target
$19.10
+76.85%
12-Month target
—
—
Intrinsic (DCF)
$276.19
Margin of safety
+89.57%
0 Strong Buy2 Buy3 Hold0 Sell1 Strong Sell
Price chart
Stock snapshot
Strengths
+ 89.57% below intrinsic value
Risks
- Thin margins at -45.60%
- Negative free cash flow $-39.20M
- Revenue declining -10.50% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $3.27B | $3.00B | $2.78B | $2.73B | $2.66B |
| Net income | $548.70M | $-10.10M | $-2.05B | $-1.13B | $-91.80M |
| EPS | — | — | — | — | $-17.85 |
| Free cash flow | $744.40M | $70.90M | $-112.10M | $-83.00M | $-39.20M |
| Profit margin | 16.80% | -0.34% | -73.74% | -41.45% | -45.60% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-22 | MCLELLAN, PHILIP D. | Sale | 3,238 | — |
| 2026-04-22 | MCLELLAN, PHILIP D. | Buy | 3,238 | — |
| 2026-04-22 | MCLELLAN, PHILIP D. | Sale | 1,162 | $11.90 |
Peer comparison
Smart narrative
Quidel Corporation trades at $10.80. Our Smart Value Score of 40/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. TTM revenue stands at $2.66B. with profit margins at -45.60%. Our DCF model estimates intrinsic value at $276.19.
Frequently asked questions
What is Quidel Corporation's stock price?
Quidel Corporation (QDEL) trades at $10.80.
Is Quidel Corporation overvalued?
Smart Value Score 40/100 (Grade D, Sell). DCF value $276.19.
What is the price target of Quidel Corporation (QDEL)?
The analyst target price is $19.10, representing +76.9% upside from the current price of $10.80.
What is the intrinsic value of Quidel Corporation (QDEL)?
Based on our DCF model, intrinsic value is $276.19, a +89.6% margin of safety versus $10.80.
What is Quidel Corporation's revenue?
TTM revenue is $2.66B.
Piotroski F-Score?
5/9 — moderate financial health.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio0.28x
ROE-49.90%
Beta0.74
50D MA$15.84
200D MA$24.51
Shares out0.07B
Float0.06B
Short ratio—
Avg volume2.3M
Performance
1 week-14.56%
1 month-22.02%
3 months-62.89%
YTD-62.18%
1 year—
3 years—
5 years—